Lv4
408 积分 2025-06-12 加入
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
48分钟前
待确认
TP53 in AML and MDS: The new (old) kid on the block
17天前
已完结
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
18天前
已完结
Acute myeloid leukaemia genomics
1个月前
已完结
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
1个月前
已完结
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
1个月前
已完结
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
1个月前
已完结
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
1个月前
已完结
New Approaches to Myelodysplastic Syndrome Treatment
1个月前
已完结
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
5个月前
已完结
皖公网安备34019202002308
